Business Context and Reporting Period
This Form 8-K Current Report was filed by Healthcare Triangle, Inc. on December 4, 2024. The filing addresses a specific regulatory event regarding the company's listing status on The Nasdaq Stock Market LLC under the trading symbol HCTI.
Key Financial Metrics
This filing is a Current Report (Item 8.01 Other Events) and does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on regulatory compliance status.
Material Changes
The primary material change reported is the resolution of a Nasdaq listing deficiency:
- Previous Status: On June 26, 2024, the company received notice that its common stock failed to maintain the required minimum bid price of $1.00 per share for 30 consecutive business days.
- Compliance Period: The company was granted a 180-day period (until December 23, 2024) to regain compliance.
- Current Status: As of December 4, 2024, the Nasdaq Staff confirmed the company regained compliance. The closing bid price was at or above $1.00 for 20 consecutive business days (October 28, 2024, to November 22, 2024).
- Outcome: The matter regarding the Minimum Bid Price Requirement is now closed.
Guidance, Outlook, and Risks
The filing contains standard forward-looking statements regarding the company's expected timeline for compliance with Nasdaq Corporate Governance Rules. Management notes that actual future results may differ materially from expectations due to risks and uncertainties beyond the company's control. No specific financial guidance or operational outlook is provided in this document.
Investor Verification Checklist
- Verify the current trading price of HCTI to ensure it remains above the $1.00 minimum bid price threshold.
- Review the company's most recent 10-K or 10-Q filings for actual financial performance data, as this 8-K contains none.
- Monitor future filings for any new Nasdaq deficiency notices regarding other listing standards (e.g., market value of listed securities, shareholder equity).
- Confirm the company's status as an "emerging growth company" and any associated reporting exemptions.